… of a hormone receptor expressing breast cancer cell line have accurately predicted the …
triple negative breast cancer cell lines and discuss their utility and the limitations of these cell …

… breast cancer who have triple-negative breast cancer. As a group, patients with triple-negative …
now at the forefront of clinical research on the treatment of triple-negative breast cancer. …

… triple-negative group of breast cancer is not a homogeneous disease entity. However, a
substantial fraction of these tumours belongs to the basal-like tumour … , and triple negativity may …

… Since triple-negative breast cancer is resistant to our current HER2-targeted therapies such
… triple-negative breast cancer, current treatment strategies and future directions for treatment. …

… type of breast cancer encountered world widely in women. Absence of hormonal receptors
on breast cancer cells necessitates the chemotherapy as the only treatment regime. High …

… Triple-negative breast cancers (TNBCs) are defined by the absence of … These cancers
represent a heterogeneous breast cancer subtype with a poor prognosis. Few systemic treatment …

… to inhibit the growth of breast cancer cell lines (MCF-7… treatment effects of 4 TN breast cancer
cell lines (MDA-MB-231, BT-20, MDA-MB-468 and BT-549) in vitro, and MDA-MB-231 cells …

… the hypothesis that TNBC exosomes may be involved in cancer cell-to-cell communication,
conferring phenotypic traits to secondary cells that reflect those of their cells of origin. …

… For breast cancer, the first clinically used predictive … The first cytogenetic predictor for breast
cancer treatment has … used in the treatment of breast cancer patients presenting with HER2 …

… was enriched in triple-negative breast cancer and associated with … therapeutic target for
triple-negative breast cancer, we … in two human triple-negative breast cancer cell lines, MDA-…